Table 2 Top enriched KEGG pathways (adjusted P < 0.1) with significantly increased genes 30 days postpartum ( P < 0.05; adjusted P < 0.1)
Enriched KEGG pathways 30 DPP | P-value | |
|---|---|---|
| Â | Over represented | Under represented |
Input - Genes with a P -value < 0.05 | Â | Â |
Focal adhesion | 4.80E-08 | 1.00E+00 |
Axon guidance | 4.62E-06 | 1.00E+00 |
Hedgehog signaling pathway | 4.75E-06 | 1.00E+00 |
ECM-receptor interaction | 1.07E-05 | 1.00E+00 |
Basal cell carcinoma | 1.83E-04 | 1.00E+00 |
Wnt signaling pathway | 2.59E-04 | 1.00E+00 |
Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 2.60E-04 | 1.00E+00 |
Melanogenesis | 9.64E-04 | 1.00E+00 |
Tight junction | 9.69E-04 | 1.00E+00 |
Cell adhesion molecules (CAMs) | 1.35E-03 | 9.99E-01 |
Input - Genes with an adjusted P -value < 0.1 | ||
Hedgehog signaling pathway | 6.03E-08 | 1.00E+00 |
Focal adhesion | 3.75E-07 | 1.00E+00 |
Basal cell carcinoma | 1.20E-06 | 1.00E+00 |
ECM-receptor interaction | 1.01E-05 | 1.00E+00 |
Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 1.51E-05 | 1.00E+00 |
Melanogenesis | 1.51E-05 | 1.00E+00 |
Wnt signaling pathway | 4.60E-05 | 1.00E+00 |
Axon guidance | 7.34E-05 | 1.00E+00 |
Pathways in cancer | 8.55E-04 | 1.00E+00 |
Protein digestion and absorption | 1.24E-03 | 1.00E+00 |